María Ángeles Castilla

Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma

María Ángeles Castilla, Gema Moreno‐Bueno, Laura Romero‐Pérez et al. · The Journal of Pathology · 2010 · 227 citations

Life Sciences, Cancer Biology, Oncology +17

Lysyl oxidase‐like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal‐like breast carcinomas

Gema Moreno‐Bueno, Fernando Salvador, Alberto Martín et al. · EMBO Molecular Medicine · 2011 · 158 citations · Full text

Medicine, Cancer Biology, Oncology +17

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

Marta Hergueta‐Redondo, David Sarrió, Ángela Molina-Crespo et al. · Oncotarget · 2016 · 118 citations · Full text

Medicine, Molecular Biology, Oncology +16

Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H₂O₂

Francisco R. González‐Pacheco, Juan J. P. Deudero, María C. Castellanos et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2006 · 105 citations

Life Sciences, Pharmacology, Cell Signaling +16

MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

María Ángeles Castilla, Juan Díaz‐Martín, David Sarrió et al. · PLoS ONE · 2012 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +17